Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
4,612
datasets available to search
ShareScore release 0.9.0
Dataset results
4,612 results for “Labels”
Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
ClinicalTrials.gov study NCT01423903. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pharmacokinetics and Metabolism of (14C)-Labelled PXL770
ClinicalTrials.gov study NCT03886103. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Study of 18F-mFBG for Imaging Neuroblastoma
ClinicalTrials.gov study NCT04724369. IPD Sharing: NO. Countries: 1. Publications: 0.
Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
ClinicalTrials.gov study NCT02167854. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open Label, Multi-centre, Non-interventional Post-marketing Surveillance to Monitor the Safety and/or Efficacy of AVANDAMET Between June 2004 and January 2010
ClinicalTrials.gov study NCT01294553. IPD Sharing: Not stated. Countries: 0. Publications: 0.
An Open Label Study to Examine the Effects of DAS181 Administered by Dry Powder Inhaler (DPI) or Nebulized Formulation in Immunocompromised Subjects With Parainfluenza (PIV) Infection
ClinicalTrials.gov study NCT01924793. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of kcal and PACE Labelling on Self-served Portion Size
ClinicalTrials.gov study NCT04340804. IPD Sharing: YES. Countries: 1. Publications: 0.
A Pilot Open-label Randomized Study of Lactofiltrum in Women With Bacterial Vaginosis
ClinicalTrials.gov study NCT01089348. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective, Open-label, Exploratory Basket Trial to Evaluate the Efficacy and Safety of Sintilimab Combined With Pyrotinib ± Chemotherapy in Patients With Advanced Digestive System Tumors
ClinicalTrials.gov study NCT07053150. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1, Non-Randomized, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics, Safety, And Tolerability Of Dimebon [PF 01913539] In Subjects With Severely-Impaired And Normal Renal Functio
ClinicalTrials.gov study NCT00824590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Activity of 90Y-Labeled IDEC-159 in Subjects With Metastatic Colorectal Adenocarcinoma
ClinicalTrials.gov study NCT00102024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Six-Month, Open-Label, Crossover Study Of the Maintenance Of Serum Testosterone And PSA Suppression After Switching Between Lupron 22.5 Mg And Eligard 22.5 Mg Or Zoladex 10.8 Mg And Eligard 22.5 Mg
ClinicalTrials.gov study NCT00220194. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open Label Extension (OLE) for the Patients Treated in the ISD002-P144-07 Study
ClinicalTrials.gov study NCT00781053. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibito
ClinicalTrials.gov study NCT01166477. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
ClinicalTrials.gov study NCT02150928. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Single Center, Open-label, Randomized, Two-period Crossover Food Effect Study of Single Doses of Tivozanib (AV-951) in Healthy Subjects
ClinicalTrials.gov study NCT01316848. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma
ClinicalTrials.gov study NCT01522872. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1, Open-Label, Dose-Escalation Study of NEV801, Administered to Patients With Advanced Cancers
ClinicalTrials.gov study NCT02797795. IPD Sharing: NO. Countries: 1. Publications: 0.
An Open Label Extension Study in Subjects With Fragile X Syndrome
ClinicalTrials.gov study NCT01555333. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use
ClinicalTrials.gov study NCT01840085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.